Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Study record dates and last-updated timestamps were updated on 2026-03-03, 2026-02-11, and 2025-12 to reflect recent maintenance.
    Difference
    0.2%
    Check dated 2026-03-04T23:51:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the prior funding notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:12:21.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    An administrative funding-status notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:31:09.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added a Show glossary option on the page and introduced QC metadata fields Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Removed the previous QC metadata items Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:33.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A minor revision label was updated from Revision: v3.3.3 to Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:50:18.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3' and removed references to 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.1%
    Check dated 2025-12-23T17:31:42.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.